Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2025-12-10 00:00:00 ET · period of report 2025-12-08 · accession 0001470831-25-000392 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-10 | 2025-12-08 | BBIO | Apuli Maricel | CAO | S - Sale | $74.26 | -2,000 | 130.3K | -2% | -$148.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-08 | S | D | 2,000 | $74.26 | 130,297 | D | — | — |